Disclosure of interest: Nothing to disclose E-Posters - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P2160 - ESOC25-1720 PROGNOSTIC VALUE OF EARLY NEUROFILAMENT LIGHT CHAIN AND GLIAL FIBRILLARY ACIDIC PROTEIN BLOOD LEVELS IN PATIENTS WITH ACUTE SPONTANEOUS INTRACEREBRAL HAEMORRHAGE lvaro Lambea-Gil 1 , Ana Aguilera-Simn 2 , Andrea Lozano-Martnez 3 , Joan Mart-Fbregas 1 , Luis Prats-Snchez 1 , Pol Camps Renom 1 , Alejandro Martinez Domeo 1 , Marina Guasch-Jimnez 1 , Garbie Ezcurra 1 , Joan Miquel Fernandez Vidal 1 , Nria Puig 2 , Esther Granell-Moreno 3 , Anna Ramos-Pachon 1 1 Stroke Unit - Department of Neurology, Hospital de la Santa Creu i Sant Pau, Sant Pau Research Institute, Barcelona, Spain, 2 Sant Pau Research Institute, Barcelona, Spain, 3 Neuroradiology Unit - Department of Radiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Background and Aims: In patients with acute spontaneous intracerebral haemorrhage (ICH), blood-based biomarkers could help to improve prognostication and decision-making processes in emergency and prehospital settings
Depending on the jurisdiction, these peptides may not be approved medicines and may be available only for legitimate laboratory research
BPC-157, TB-500, and growth hormone peptides often become staples in ongoing optimization protocols
What patients notice first depends on their individual baseline
Before you book an appointment or pay for a package, you need an honest answer to a simple question: does the clinical evidence actually support these claims
